Escitalopram for the prevention of peginterferon alpha-2a- and ribavirin-associated depression in HCV-infected patients without prior psychiatric disease: A randomized controlled trial

Martin Schaefer, Rahul Sarkar, Viola Weich, Susanne Effenberger, Astrid Friebe, Loni Heinze, Ulrich Spengler, Thomas Schläpfer, Jens Reimer, Peter Buggisch, Johann Ockenga, Ralph Link, Michael Rentrop, Hans Weidenbach, Gwendolyn Fromm, Klaus Lieb, Thomas F. Baumert, Andreas Heinz, Thomas Discher, Konrad Neumann, Stefan Zeuzem, Thomas Berg
  • Neurology Psychiatry and Brain Research, March 2012, Elsevier
  • DOI: 10.1016/j.npbr.2012.02.036

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Thomas E. Schlaepfer